• AAPL 182.9499
  • TSLA 174.6997
  • AMZN 187.92
  • MSFT 411.28
  • INTC 29.935
  • EURUSD 1.0748
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NEO /
  3. PFE.NEO

Pfizer Inc CDR (PFE NEO) stock market data APIs

C$13.28 0.27(2.1%) as of May 7, 2024

Pfizer Inc CDR Financial Data Overview

13.01
13.28
-
13.33
12.84
11.83-18.586
218 342 M
14 710 M
54 889 M
0.0602
0.572
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PFE',
Type: 'Common Stock',
Name: 'Pfizer Inc CDR',
Exchange: 'NEO',
CurrencyCode: 'CAD',
CurrencyName: 'Canadian Dollar',
CurrencySymbol: 'C$',
CountryName: 'Canada',
CountryISO: 'CA',
OpenFigi: NULL,
ISIN: 'CA7170651060',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
}

Pfizer Inc CDR Fundamental Data is available in our Financial Data APIs

  • Net Revenue 54 889 M
  • EBITDA 9 444 M
  • Earnings Per Share -0.03
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Pfizer Inc CDR Earnings via APIs

  • Latest Release 2024-04-25
  • EPS/Forecast NaN

Get Pfizer Inc CDR End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Pfizer Inc CDR latest news via APIs

UPDATE 2-Pfizer reports patient death in Duchenne gene therapy study

(Adds company response in paragraphs 9 to 10, details and background throughout) May 7 (Reuters) - A young patient died due to cardiac arrest after receiving Pfizer's experimental gene therapy being ...

Pfizer reports patient death in Duchenne gene therapy study

May 7 (Reuters) - A young boy died due to a cardiac arrest in a mid-stage trial that tested Pfizer's experimental gene therapy for a muscle-wasting disorder called Duchenne muscular dystrophy (DMD), t...
Do you have any questions?
support@eodhistoricaldata.com